WW International: The Party Won't Last Long
WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...
Hosted on MSN11d
WeightWatchers (NASDAQ:WW) Stock Jumps 40% on Plan to Sell Obesity Medications
Shares of WeightWatchers parent company WW International ($WW) have rocketed 40% higher on news that the company plans to ...
WW International(WW.US)收涨近38%！将复合司美格鲁肽纳入减肥方案
智通财经APP获悉，周三，减肥解决方案提供商WW International(WW.US)收涨近38%，报1.60美元。消息面上，WW International宣布将compounded ...
WW International surges as Morgan Stanley says GLP-1 entry 'not too late'
WW International (WW) shares surged more than 20% in early trading on Wednesday after Morgan Stanley said the company's ...
美股异动丨WW International涨超15.6% 将复合司美格鲁肽添加到其减肥方案中
减肥解决方案供应商WW International (WW.US)涨超15.6%，报0.91美元。消息面上，WW ...
WW International: Strategic Shift Amid Market Challenges – A Balanced Hold Rating
WW International (WW – Research Report), the Consumer Cyclical sector company, was revisited by a Wall Street analyst yesterday. Analyst ...
Hold Rating on WW International Amid New Semaglutide Offering and Optimistic Revenue Projections
In a report released today, Alex Fuhrman from Craig-Hallum maintained a Hold rating on WW International (WW – Research Report), with a ...
Investopedia on MSN12d
WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering
Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat weight-loss ...
减肥解决方案提供商WW International盘前涨6%
WW International（WW.US）盘前涨6%报1.76美元。消息上，美国FDA将重新考虑禁止利拉的减肥药复方版本的决定。公司此前宣布将compounded ...
WW International股价面临压力，巴克莱银行对复合药物长期可行性表示担忧
周二，巴克莱银行重申了对WW International Inc (NASDAQ:WW)股票的减持评级，目标价维持在$0.75。尽管WW宣布推出复合塞马格鲁肽产品，预计将提供短期增长机会，但巴克莱对复合业务模式的可持续性持谨慎态度。尽管WW股价今天上涨了5%，巴克莱仍保持谨慎。 WW通过其WW Clinical平台推出新产品，起价为$129。此举旨在满足对复合GLP-1的高需求，并延长公司的现金周 ...